PubMed laboratory research record [PMID: 29516855] PubMed record related to this compound for laboratory literature review
Depending on which meaning is adopted, there are two quite different approaches
Its simply one part of a healthy lifestyle
these factors make GLP-1 RAs an alternative initial treatment option, with or without metformin based on glycemic needs, in T2DM patients with indicators of high-risk or established heart failure (HF) or CKD who cannot tolerate an SGLT2 inhibitor
The honest assessment is that both remain experimental in the contexts most patients seek them for, and the decision comes down to risk tolerance, financial capacity, and how much weight you place on preclinical versus early-stage clinical data
Possible mild effects : local injection site soreness, slight flushing Rare : nausea, dizziness, allergic reaction Contraindications : hypersensitivity to any component